These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 21712403

  • 21. Branch retinal artery occlusion after excessive use of nasal spray.
    Magargal LE, Sanborn GE, Donoso LA, Gonder JR.
    Ann Ophthalmol; 1985 Aug; 17(8):500-1. PubMed ID: 2413795
    [Abstract] [Full Text] [Related]

  • 22. Revised product labels for pediatric over-the-counter cough and cold medicines.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2008 Oct 31; 57(43):1180. PubMed ID: 18971921
    [Abstract] [Full Text] [Related]

  • 23. Paradoxical increase in nasal airway resistance following a topical nasal decongestant spray.
    Doddi NM, Eccles R.
    Rhinology; 2011 Mar 31; 49(1):127. PubMed ID: 21468388
    [Abstract] [Full Text] [Related]

  • 24. Nasal decongestant therapy.
    Stride RD.
    Br J Clin Pract; 1967 Nov 11; 21(11):541-8. PubMed ID: 4169455
    [No Abstract] [Full Text] [Related]

  • 25. For coughs and colds, older patients need alternatives to PPA products.
    Geriatrics; 2001 Jan 11; 56(1):16. PubMed ID: 11196333
    [No Abstract] [Full Text] [Related]

  • 26. Cerebral infarcts in a pediatric patient secondary to phenylpropanolamine, a recalled medication.
    Delorio NM.
    J Emerg Med; 2004 Apr 11; 26(3):305-7. PubMed ID: 15028328
    [Abstract] [Full Text] [Related]

  • 27. Acute and chronic conjunctivitis due to over-the-counter ophthalmic decongestants.
    Soparkar CN, Wilhelmus KR, Koch DD, Wallace GW, Jones DB.
    Arch Ophthalmol; 1997 Jan 11; 115(1):34-8. PubMed ID: 9006422
    [Abstract] [Full Text] [Related]

  • 28. Depression and decongestants.
    Climko RP.
    Am J Psychiatry; 1987 Oct 11; 144(10):1376-7. PubMed ID: 2444119
    [No Abstract] [Full Text] [Related]

  • 29. Misuse of over-the-counter cough or cold medications among adolescents: prevalence and correlates in a national sample.
    Ford JA.
    J Adolesc Health; 2009 May 11; 44(5):505-7. PubMed ID: 19380101
    [Abstract] [Full Text] [Related]

  • 30. Visual disturbances associated with over-the-counter ibuprofen in three patients.
    Nicastro NJ.
    Ann Ophthalmol; 1989 Dec 11; 21(12):447-50. PubMed ID: 2627094
    [Abstract] [Full Text] [Related]

  • 31. An unusual case of systemic cardiovascular side effects from the application of over-the-counter nasal decongestion drops.
    Browning MG, Seddon JO, Yung LT, Gough G.
    BMJ Case Rep; 2011 Mar 24; 2011():. PubMed ID: 22699473
    [Abstract] [Full Text] [Related]

  • 32. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of final monograph for over-the-counter nasal decongestant drug products. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2005 Oct 11; 70(195):58974-7. PubMed ID: 16217879
    [Abstract] [Full Text] [Related]

  • 33. [Children and nasal decongestants].
    Tidsskr Nor Laegeforen; 1973 Jan 30; 93(3):186. PubMed ID: 4120905
    [No Abstract] [Full Text] [Related]

  • 34. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.
    Graf P.
    Rhinology; 1996 Mar 30; 34(1):9-13. PubMed ID: 8739860
    [Abstract] [Full Text] [Related]

  • 35. [Rhinitis medicamentosa].
    Finsnes KA.
    Tidsskr Nor Laegeforen; 1987 Jun 20; 107(17-18):1558-9. PubMed ID: 2440127
    [No Abstract] [Full Text] [Related]

  • 36. OTC, DTC, a stuffy nose, cocaine, and methamphetamine.
    Flaskerud JH, Strehlow AJ.
    Issues Ment Health Nurs; 2008 Sep 20; 29(9):1041-4. PubMed ID: 18770107
    [No Abstract] [Full Text] [Related]

  • 37. [Nasal drops addiction--the case report].
    Korzeniowska K, Simon K, Jabłecka A.
    Przegl Lek; 2012 Sep 20; 69(10):1168-9. PubMed ID: 23421118
    [Abstract] [Full Text] [Related]

  • 38. Allergy, cold sufferers must cope with effects of OTC medications.
    Vaughan E.
    Occup Health Saf; 1991 Apr 20; 60(4):28, 30. PubMed ID: 1711185
    [No Abstract] [Full Text] [Related]

  • 39. Topical nasal decongestants.
    Engle JP.
    Am Pharm; 1992 May 20; NS32(5):33-7. PubMed ID: 1375430
    [No Abstract] [Full Text] [Related]

  • 40. Angle closure risk from proprietary medicines.
    Barrett V, Jordan T.
    Eye (Lond); 2001 Apr 20; 15(Pt 2):248-9. PubMed ID: 11339612
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.